JT Goodman, JE Vela Ramirez, R Roychoudhury, PM Boggiatto, NLB Pohl, MJ Wannemuehler, and B Narasimhan, “Nanoparticle chemistry and functionalization differentially regulates dendritic cell-nanoparticle interactions and triggers dendritic cell maturation,” Particle & Particle Syst Charact 31(12), 1269-80 (2014)
SL Haughney, KA Ross, PM Boggiatto, MJ Wannemuehler, and B Narasimhan, “Effect of nanovaccine chemistry on humoral immune response kinetics and maturation,” Nanoscale 6(22), 13770-8 (2014)
JE Vela-Ramirez, R Roychoudhury, HH Habte, MW Cho, NLB Pohl, and B Narasimhan, “Carbohydrate-functionalized nanovaccines preserve HIV antigen stability and activate antigen presenting cells,” J Biomater Sci Polym Ed 25(13), 1387-1406 (2014)
KA Ross, W Wu, H Loyd, L Huntimer, S Carpenter, MJ Wannemuehler, and B Narasimhan, “Structural stability and antigenicity of H5N1 hemagglutinin trimer upon release from polyanhydride nanoparticles,” J Biomed Mater Res A 102, 4161-4168 (2014)
KA Ross, LM Huntimer, JE Vela-Ramirez, JR Adams, SL Carpenter, ML Kohut, T Bronich, R Webby, KL Legge, SK Mallapragada, MJ Wannemuehler, and B Narasimhan, “Vaccine technologies against avian influenza: current approaches and new directions,” J Biomed Nanotechnol 10(9), 2261-2294 (2014)
NA Peppas and B Narasimhan, “Mathematical models in drug delivery: how modeling has shaped the way we design new drug delivery systems,” J Contr Rel 190, 75-81 (2014)
LM Huntimer, KA Ross, RJ Darling, NE Winterwood, PM Boggiatto, B Narasimhan, AE Ramer-Tait, and MJ Wannemuehler, “Polyanhydride nanovaccine platform enhances antigen-specific cytotoxic T cell responses,” Technology 2(2), 171-175 (2014)
KA Ross, SL Haughney, LK Petersen, PM Boggiatto, MJ Wannemuehler, and B Narasimhan, “Deposition and uptake behavior of pathogen-mimicking nanovaccines in the first 48 hours,” Adv Healthcare Mater 3(7), 1071-1077 (2014)
BD Ulery, H-M Kan, BC Williams, B Narasimhan, KWH Lo, LS Nair, and CT Laurencin, “Facile fabrication of polyanhydride/anesthetic nanoparticles with tunable release kinetics,” Adv Healthcare Mater 3(6), 843-847 (2014)
Y Phanse, B Carrillo-Conde, AE Ramer-Tait, SR Broderick, CS Kong, K Rajan, R Flick, R Mandell, BH Bellaire, MJ Wannemuehler, and B Narasimhan, “A systems approach to designing next generation vaccines: combining amphiphilic nanoparticle platforms with α-galactose modified antigens,” Sci Reports 4, 3775, DOI:10.1038/srep03775 (2014)
F Jia, B Narasimhan, and SK Mallapragada, “Materials-based strategies for multi-enzyme immobilization and co-localization: a review,” Biotechnol Bioeng 111, 209-222 (2014)
SL Haughney, P Lueth, D Wagner, TW Dubensky, BH Bellaire, B Narasimhan, and MJ Wannemuehler, “Polyanhydride nanovaccine and cyclic dinucleotide based formulations stimulate innate immunity and modulate immune response,” Trans Soc Biomater, 37, 124 (2014)
JV Ramirez, J Goodman, R Roychoudhury, P Boggiato, NLB Pohl, MJ Wannemuehler, and B Narasimhan, “In vivo evaluation of safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles,” Trans Soc Biomater, 37, 537 (2014)
KA Ross, H Loyd, W Wy, LM Huntimer, S Ahmed, A Sambol, Z Flickinger, S Hinrichs, T Bronich, SK Mallpragada, MJ Wannemuehler, SL Carpenter, and B Narasimhan, “Polyanhydride nanovaccines elicit protective virus neutralizing titers and cell-mediated immunity against influenza,” Trans Soc Biomater, 37, 538 (2014)
T Brenza, MJ Wannemuehler, and B Narasimhan, “Size and chemistry affect cellular distribution after intranasal administration of nanoparticles,” Trans Soc Biomater, 37, 700 (2014)